MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$23,466
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from sale of common sto...
Proceeds from notes payable
Accrued compensation
Others
Negative Cash Flow Breakdown
Net (loss)
Repayments of note payable
Amortization of right-of-use ass...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-
-
2,669,348
-
Net (loss)
-284,140
1,816,598
-
-2,132,440
Stock for services and compensation
0
0
0
0
Write-off of inventory
-
-
0
0
(gain) loss on settlement of debt
-
-
0
-
Amortization expense
1,012
1,013
1,013
1,012
Amortization of right-of-use asset
-233
-350
-810
-
Amortization of debt discount
11,946
9,276
1,649
-
Amortization of right-of-use asset
-
-
-
-350
(gain) loss on derivative liabilities
-33,898
22,404
28,334
-
Gain on settlement of debt
-
-
-
0
Inventory
-
-
0
-
Security deposit used for rent
2,850
-
-
-
Prepaid and other current assets
-6,002
6,028
15,390
3,867
Accounts payable and accrued expenses
15,183
179,240
-13,038
112,382
Accrued liabilities - related party
30,369
24,556
21,731
21,731
Repayments of advance from related party
-
-
145,000
-
Accrued compensation
45,100
46,200
16,500
-20,471
Proceeds from note payable - related party
-
-
250,000
-
Net cash used in operating activities
-138,013
-84,339
-553,127
-175,157
Proceeds from promissory note payable
-
-
0
-
Net cash used in investing activities
0
0
0
0
Proceeds from convertible notes payable
0
0
350,000
130,000
Advances from related party
0
0
125,000
0
Repayment of advance from related party
-20,000
-
-
0
Payment of offering costs
-
-
-
2,400
Proceeds from sale of common stock
100,674
-
-
-
Proceeds from notes payable
70,000
26,250
-
0
Payment of offering costs
-
-
2,400
-
Proceeds from sale of common stock
-
-
0
65,708
Proceeds from sale of units
-
-
0
-
Repayments of note payable
9,195
6,131
-
-
Net cash provided by financing activities
161,479
20,119
600,000
193,308
Increase (decrease) in cash and cash equivalents
23,466
-64,220
46,873
18,151
Cash and cash equivalents - beginning of period
1,029
65,249
18,376
168,883
Cash and cash equivalents - end of period
24,495
1,029
65,249
18,376
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sale of
common stock
$100,674
Proceeds from notes
payable
$70,000
Repayment of advance from
related party
-$20,000
(-200.00%↓ Y/Y)
Net cash provided by
financing activities
$161,479
(-44.32%↓ Y/Y)
Canceled cashflow
$29,195
Increase (decrease) in
cash and cash...
$23,466
(113.91%↑ Y/Y)
Canceled cashflow
$138,013
something is missing
-$20,000
Repayments of note payable
$9,195
Accrued compensation
$45,100
(-52.64%↓ Y/Y)
(gain) loss on
derivative liabilities
-$33,898
Accrued liabilities -
related party
$30,369
(-30.13%↓ Y/Y)
Accounts payable and
accrued expenses
$15,183
(-87.91%↓ Y/Y)
Amortization of debt discount
$11,946
Prepaid and other
current assets
-$6,002
(-213.58%↓ Y/Y)
Security deposit used for
rent
$2,850
Amortization expense
$1,012
(-50.02%↓ Y/Y)
Net cash used in
operating activities
-$138,013
(69.91%↑ Y/Y)
Canceled cashflow
$146,360
Net (loss)
-$284,140
(84.61%↑ Y/Y)
Amortization of right-of-use
asset
-$233
(-111.82%↓ Y/Y)
Buy us a coffee
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)